Alberta Investment Management Corp (AIMCo)’s Pacira BioSciences PCRX Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9,817	Closed	-$379K	–	1291
2022 Q4	$379K	Sell	9,817 -431	-4%	-$21K	﹤0.01%	949
2022 Q3	$545K	Hold	10,248	–	–	﹤0.01%	1052
2022 Q2	$597K	Hold	10,248	–	–	﹤0.01%	1029
2022 Q1	$782K	Buy	10,248 +1,067	+12%	+$71.1K	﹤0.01%	1039
2021 Q4	$552K	Buy	+9,181	New	+$506K	﹤0.01%	869
2017 Q1	–	Sell	-64,900	Closed	-$2.1M	–	879
2016 Q4	$2.1M	Buy	64,900 +15,100	+30%	+$504K	0.02%	449
2016 Q3	$1.7M	Hold	49,800	–	–	0.02%	463
2016 Q2	$1.68M	Buy	49,800 +28,820	+137%	+$1.42M	0.02%	450
2016 Q1	$1.11M	Sell	20,980 -67,815	-76%	-$3.97M	0.01%	442
2015 Q4	$6.82M	Sell	88,795 -118,560	-57%	-$6.71M	0.08%	282
2015 Q3	$8.52M	Hold	207,355	–	–	0.1%	253
2015 Q2	$14.7M	Buy	207,355 +102,520	+98%	+$8.07M	0.16%	151
2015 Q1	$9.31M	Buy	+104,835	New	+$10.6M	0.1%	282

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s PCRX Position: Q1 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of Pacira BioSciences (PCRX) in Q1 2023, closing a stake of 9,817 shares — an estimated $379K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in PCRX in Q1 2015 and held it in 13 quarters. The position peaked at $14.7M in Q2 2015. 267 funds tracked by Wall St. Rank hold PCRX as of Q1 2023.

Alberta Investment Management Corp (AIMCo) reported no remaining Pacira BioSciences position as of Q1 2023 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 9,817 Pacira BioSciences shares in Q1 2023, an estimated $379K.
Alberta Investment Management Corp (AIMCo) first reported a position in Pacira BioSciences in Q1 2015 and held it in 13 quarters.
Alberta Investment Management Corp (AIMCo)'s Pacira BioSciences position peaked at $14.7M in Q2 2015.
267 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2023, filed 15 May 2023.